256 related articles for article (PubMed ID: 3694702)
1. The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in human adipose tissue.
Byard JL
J Toxicol Environ Health; 1987; 22(4):381-403. PubMed ID: 3694702
[TBL] [Abstract][Full Text] [Related]
2. How toxic is 2,3,7,8-tetrachlorodibenzodioxin to humans?
Kimbrough RD
J Toxicol Environ Health; 1990 Aug; 30(4):261-71. PubMed ID: 2201785
[TBL] [Abstract][Full Text] [Related]
3. Health impact of polychlorinated dibenzo-p-dioxins: a critical review.
Mukerjee D
J Air Waste Manag Assoc; 1998 Feb; 48(2):157-65. PubMed ID: 9517323
[TBL] [Abstract][Full Text] [Related]
4. Relative differences in aryl hydrocarbon receptor-mediated response for 18 polybrominated and mixed halogenated dibenzo-p-dioxins and -furans in cell lines from four different species.
Olsman H; Engwall M; Kammann U; Klempt M; Otte J; Bavel Bv; Hollert H
Environ Toxicol Chem; 2007 Nov; 26(11):2448-54. PubMed ID: 17941736
[TBL] [Abstract][Full Text] [Related]
5. Health risks of "dioxins": a review of environmental and toxicological considerations.
Dickson LC; Buzik SC
Vet Hum Toxicol; 1993 Feb; 35(1):68-77. PubMed ID: 8434461
[TBL] [Abstract][Full Text] [Related]
6. Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 1. Blood cell receptors in volunteers with moderately increased body burdens.
Neubert R; Maskow L; Webb J; Jacob-Müller U; Nogueira AC; Delgado I; Helge H; Neubert D
Life Sci; 1993; 53(26):1995-2006. PubMed ID: 8255162
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to environmental polychlorinated dibenzo-p-dioxins and dibenzofurans: an exposure commitment assessment for 2,3,7,8-TCDD.
Jones KC; Bennett BG
Sci Total Environ; 1989 Jan; 78():99-116. PubMed ID: 2717930
[TBL] [Abstract][Full Text] [Related]
8. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues.
Leung HW; Wendling JM; Orth R; Hileman F; Paustenbach DJ
Toxicol Lett; 1990 Feb; 50(2-3):275-82. PubMed ID: 2309246
[TBL] [Abstract][Full Text] [Related]
9. [Polychlorinated dibenzo-p-dioxins in the subcutaneous adipose tissue of yusho patients].
Iida T; Nakagawa R; Fukamachi K; Takahashi K
Fukuoka Igaku Zasshi; 1989 May; 80(5):302-6. PubMed ID: 2501197
[TBL] [Abstract][Full Text] [Related]
10. Approach to risk assessment of PCDDs and PCDFs in Canada.
Feeley MM; Grant DL
Regul Toxicol Pharmacol; 1993 Dec; 18(3):428-37. PubMed ID: 8128004
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition.
Kreuzer PE; Csanády GA; Baur C; Kessler W; Päpke O; Greim H; Filser JG
Arch Toxicol; 1997; 71(6):383-400. PubMed ID: 9195020
[TBL] [Abstract][Full Text] [Related]
12. Levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Patterson DG; Fingerhut MA; Roberts DW; Needham LL; Sweeney MH; Marlow DA; Andrews JS; Halperin WE
Am J Ind Med; 1989; 16(2):135-46. PubMed ID: 2773945
[TBL] [Abstract][Full Text] [Related]
13. Acute toxicity in the guinea pig and in vitro "dioxin-like" activity of the environmental contaminant 1,2,4,5,7,8-hexachloro (9H)xanthene.
DeCaprio AP; Briggs R; Gierthy JF; Kim JC; Kleopfer RD
J Toxicol Environ Health; 1987; 20(3):241-8. PubMed ID: 3820338
[TBL] [Abstract][Full Text] [Related]
14. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies.
Greene JF; Hays S; Paustenbach D
J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432
[TBL] [Abstract][Full Text] [Related]
15. A time-dependent 2,3,7,8-tetrachlorodibenzo-p-dioxin body-burden model.
Craig TO; Grzonka RB
Arch Environ Contam Toxicol; 1991 Sep; 21(3):438-46. PubMed ID: 1953032
[TBL] [Abstract][Full Text] [Related]
16. Uncertainties related to the assignment of a toxic equivalency factor for 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin.
Sutter CH; Rahman M; Sutter TR
Regul Toxicol Pharmacol; 2006 Apr; 44(3):219-25. PubMed ID: 16460856
[TBL] [Abstract][Full Text] [Related]
17. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
Emond C; Birnbaum LS; DeVito MJ
Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
[TBL] [Abstract][Full Text] [Related]
18. Specific responses of bacterial cells to dioxins.
Min J; Pham CH; Gu MB
Environ Toxicol Chem; 2003 Feb; 22(2):233-8. PubMed ID: 12558152
[TBL] [Abstract][Full Text] [Related]
19. Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Webb KB; Evans RG; Knutsen AP; Roodman ST; Roberts DW; Schramm WF; Gibson BB; Andrews JS; Needham LL; Patterson DG
J Toxicol Environ Health; 1989; 28(2):183-93. PubMed ID: 2677396
[TBL] [Abstract][Full Text] [Related]
20. Persistence of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) in hepatic and adipose tissue of marmoset monkeys.
Neubert D; Wiesmüller T; Abraham K; Krowke R; Hagenmaier H
Arch Toxicol; 1990; 64(6):431-42. PubMed ID: 2125825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
